🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 18 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/06/2022 | 230,15 | 230,15 | 222,03 | 228,23 | -1,32% | 3,53% | 428.200 |
| 01/06/2022 | 232,34 | 234,53 | 226,43 | 231,29 | +0,41% | 3,49% | 436.800 |
| 31/05/2022 | 230,86 | 233,66 | 227,96 | 230,34 | -2,33% | 2,47% | 633.700 |
| 27/05/2022 | 226,12 | 236,06 | 223,02 | 235,83 | +4,92% | 5,77% | 544.100 |
| 26/05/2022 | 225,95 | 227,96 | 221,56 | 224,78 | -1,58% | 2,83% | 590.600 |
| 25/05/2022 | 219,99 | 229,82 | 217,14 | 228,39 | +4,31% | 5,76% | 828.000 |
| 24/05/2022 | 210,50 | 220,02 | 209,12 | 218,95 | +4,19% | 5,18% | 996.000 |
| 23/05/2022 | 188,81 | 217,85 | 188,81 | 210,14 | +11,58% | 15,38% | 1.532.400 |
| 20/05/2022 | 188,07 | 188,88 | 184,58 | 188,33 | +1,08% | 2,29% | 465.800 |
| 19/05/2022 | 184,66 | 187,80 | 182,39 | 186,31 | +0,50% | 2,93% | 254.400 |
| 18/05/2022 | 188,51 | 192,20 | 184,86 | 185,38 | -2,94% | 3,89% | 370.300 |
| 17/05/2022 | 186,20 | 191,25 | 186,20 | 190,99 | +3,17% | 2,71% | 503.800 |
| 16/05/2022 | 183,94 | 189,87 | 182,25 | 185,13 | +0,92% | 4,14% | 203.400 |
| 13/05/2022 | 182,04 | 185,01 | 181,54 | 183,44 | +1,14% | 1,91% | 792.400 |
| 12/05/2022 | 179,96 | 182,48 | 178,74 | 181,37 | +1,05% | 2,08% | 419.700 |
| 11/05/2022 | 177,63 | 184,26 | 177,63 | 179,49 | +0,21% | 3,73% | 514.000 |
| 10/05/2022 | 181,09 | 183,90 | 174,36 | 179,11 | +0,30% | 5,27% | 729.900 |
| 09/05/2022 | 181,78 | 184,95 | 177,91 | 178,58 | -2,99% | 3,87% | 414.800 |
| 06/05/2022 | 183,87 | 187,02 | 181,19 | 184,09 | -1,55% | 3,17% | 610.300 |
| 05/05/2022 | 190,02 | 193,33 | 184,34 | 186,99 | +0,34% | 4,73% | 364.400 |
| 04/05/2022 | 190,62 | 191,78 | 179,68 | 186,36 | +3,72% | 6,35% | 655.900 |
| 03/05/2022 | 180,57 | 182,32 | 177,42 | 179,68 | -0,08% | 2,71% | 338.500 |
| 02/05/2022 | 176,86 | 180,70 | 175,43 | 179,82 | +1,27% | 2,98% | 232.800 |
| 29/04/2022 | 178,73 | 182,93 | 175,84 | 177,56 | -0,99% | 3,97% | 236.700 |
| 28/04/2022 | 178,77 | 179,44 | 175,27 | 179,34 | +1,15% | 2,33% | 205.000 |
| 27/04/2022 | 175,77 | 177,87 | 173,22 | 177,30 | +1,42% | 2,65% | 479.400 |
| 26/04/2022 | 184,19 | 185,84 | 174,67 | 174,81 | -6,14% | 6,06% | 575.000 |
| 25/04/2022 | 186,31 | 187,49 | 181,28 | 186,24 | -0,74% | 3,33% | 240.000 |
| 22/04/2022 | 192,83 | 195,07 | 186,88 | 187,63 | -1,36% | 4,25% | 379.600 |
| 21/04/2022 | 188,55 | 191,46 | 186,86 | 190,22 | +1,58% | 2,44% | 327.600 |